GLOBAL eye health company Bausch + Lomb and PhysIOL, a Liege, Belgium-based manufacturer of intraocular lenses, announced that Bausch + Lomb will begin distributing several lines of PhysIOL's hydrophilic acrylic intraocular lenses (IOLs) in select markets across Asia, Europe and the Middle East beginning this month.
PhysIOL Ankoris hydrophilic acrylic intraocular lens (PRNewsFoto/Bausch + Lomb)
As per the terms of the agreement, Bausch + Lomb will now begin to distribute PhysIOL's FineVision? trifocal and FineVision? trifocal toric hydrophilic, UV and blue-blocking, aspheric intraocular lenses, and, when available, the Ankoris? toric lenses on an exclusive or co-exclusive basis depending on the market. Additionally, Bausch + Lomb will distribute PhysIOL's Micro line of hydrophilic preloaded, UV and blue- blocking, aspheric monofocal intraocular lenses in limited markets.
"This partnership with Bausch + Lomb gives PhysIOL a perfect opportunity to leverage its R&D through a worldwide distribution network and in combination with a comprehensive line of equipment, instruments and other surgical products," said Marc Nolet, chief executive officer, PhysIOL.
The companies have the option to expand the distribution relationship over time. PhysIOL's portfolio complements Bausch + Lomb's extensive line of hydrophobic and hydrophilic acrylic IOLs, including the enVista?, Crystalens?, and Akreos? brands of IOLs for implantation after cataract removal.

Login/Register
Supplier Login
















